Lv1
48 积分 2024-03-15 加入
Divarasib as Compared with Sotorasib or Adagrasib in KRAS G12C–Mutated NSCLC
2天前
已完结
Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China
2天前
已完结
Clinical factors and molecular co-alterations impact outcomes in patients receiving first-line osimertinib for EGFR-mutated non-small cell lung cancer
1个月前
已完结
The current landscape of using direct inhibitors to target KRASG12C-mutated NSCLC
2个月前
已完结
Pharmacokinetics, mass balance, and metabolism of [14C]PLB1004, a selective and irreversible EGFR-TKI in humans
6个月前
已完结
Methylation status of epidermal growth factor receptor gene in lung carcinoma cells
7个月前
已完结
Characteristics, treatment patterns, and clinical outcomes in patients with advanced non-small cell lung cancer harboring EGFR exon 20 insertions
7个月前
已完结
Pharmacokinetics, mass balance, and metabolism of [14C]PLB1004, a selective and irreversible EGFR-TKI in humans
7个月前
已完结
Overcoming therapy resistance in EGFR-mutant lung cancer
7个月前
已完结
EGFR exon 20 insertion mutations in Chinese advanced non-small cell lung cancer patients: Molecular heterogeneity and treatment outcome from nationwide real-world study
8个月前
已完结